Trevi Therapeutics Inc (TRVI)
2.70
+0.11
(+4.25%)
USD |
NASDAQ |
Apr 18, 16:00
2.70
0.00 (0.00%)
After-Hours: 19:55
Trevi Therapeutics Price to Book Value: 2.256 for April 18, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 17, 2024 | 2.164 |
| April 16, 2024 | 2.226 |
| April 15, 2024 | 2.348 |
| April 12, 2024 | 2.439 |
| April 11, 2024 | 2.490 |
| April 10, 2024 | 2.281 |
| April 09, 2024 | 2.406 |
| April 08, 2024 | 2.619 |
| April 05, 2024 | 2.565 |
| April 04, 2024 | 2.594 |
| April 03, 2024 | 2.640 |
| April 02, 2024 | 2.698 |
| April 01, 2024 | 2.807 |
| March 28, 2024 | 2.882 |
| March 27, 2024 | 2.899 |
| March 26, 2024 | 2.832 |
| March 25, 2024 | 2.799 |
| March 22, 2024 | 2.999 |
| March 21, 2024 | 3.091 |
| March 20, 2024 | 2.957 |
| March 19, 2024 | 2.862 |
| March 18, 2024 | 2.688 |
| March 15, 2024 | 2.771 |
| March 14, 2024 | 2.589 |
| March 13, 2024 | 2.457 |
| Date | Value |
|---|---|
| March 12, 2024 | 2.391 |
| March 11, 2024 | 2.366 |
| March 08, 2024 | 2.349 |
| March 07, 2024 | 2.440 |
| March 06, 2024 | 2.540 |
| March 05, 2024 | 2.482 |
| March 04, 2024 | 2.432 |
| March 01, 2024 | 2.424 |
| February 29, 2024 | 2.416 |
| February 28, 2024 | 2.424 |
| February 27, 2024 | 2.291 |
| February 26, 2024 | 2.242 |
| February 23, 2024 | 2.060 |
| February 22, 2024 | 2.151 |
| February 21, 2024 | 2.192 |
| February 20, 2024 | 2.267 |
| February 16, 2024 | 2.258 |
| February 15, 2024 | 1.969 |
| February 14, 2024 | 1.754 |
| February 13, 2024 | 1.522 |
| February 12, 2024 | 1.464 |
| February 09, 2024 | 1.357 |
| February 08, 2024 | 1.249 |
| February 07, 2024 | 1.216 |
| February 06, 2024 | 1.208 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5591
Minimum
Mar 30 2020
11.94
Maximum
Apr 25 2022
2.032
Average
1.630
Median
Jun 22 2023
Price to Book Value Benchmarks
| Accuray Inc | 4.599 |
| Vanda Pharmaceuticals Inc | 0.5253 |
| NovaBay Pharmaceuticals Inc | 1.812 |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.6743 |
Price to Book Value Related Metrics
| Price | 2.70 |
| Earnings Yield | -10.74% |
| Market Cap | 186.19M |